Tierarztl Prax Ausg K Kleintiere Heimtiere 2010; 38(S 01): S50-S56
DOI: 10.1055/s-0038-1622888
Ausgewählter Kongressbeitrag
Schattauer GmbH

Topische Therapien in der Dermatologie – macht das Sinn?

M. Linek
1   Tierärztliche Spezialisten, Hamburg
› Author Affiliations
Further Information

Publication History

Publication Date:
05 January 2018 (online)


  • Literatur

  • 1 Bensignor E, Bourdeau W. Utilisation d’un spot-on à base d’acides gras et d’huiles essentielles pour carnivores domestiques: étude ouverte. Inf Dermatol Vét 2005; 10: 24-28.
  • 2 Bond R, Rose JF, Ellis JW, Lloyd DH. Comparison of two shampoos for treatment of Malassezia pachydermatis-associated seborrhoeic dermatitis in basset hounds. J Small Anim Pract 1995; 36 (03) 99-104.
  • 3 Brazzini B, Pimpinelli N. New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use. Am J Clin Dermatol 2002; 3 (01) 47-58.
  • 4 Chamlin SL, Kao J, Frieden IJ, Sheu MY, Fowler AJ, Fluhr JW, Williams ML, Elias PM. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 2002; 47 (02) 198-208.
  • 5 Hnilica KA, Medleau L. Evaluation of topically applied enilconazole for the treatment of dermatophytosis in a Persian cattery. Vet Dermatol 2002; 13 (01) 23-28.
  • 6 Kwochka KW, Kowalski JJ. Prophylactic efficacy of four antibacterial shampoos against Staphylococcus intermedius in dogs. Am J Vet Res 1991; 52 (01) 115-118.
  • 7 Loeffler A, Baines SJ, Toleman MS, Felmingham D, Milsom SK, Edwards EA, Lloyd DH. In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pet. J Antimicrob Chemother 2008; 62 (06) 1301-1304.
  • 8 Loeffler A, Linek M, Moodley A, Guardabassi L, Sung JM, Winkler M, Weiss R, Lloyd DH. First report of multiresistant, mecA-positive Staphylococcus intermedius in Europe: 12 cases from a veterinary dermatology referral clinic in Germany Vet Dermatol. 2007; 18 (06) 412-421.
  • 9 Loflath A, Voigts-Rhetz A, Jaeger K, Schmid M, Kuechenhoff H, Mueller RS. The efficacy of a commercial shampoo and whirlpooling in the treatment of canine pruritus – a double-blinded, randomized, placebo-controlled study. Vet Dermatol 2007; 18 (06) 427-431.
  • 10 Marsella R, Girolomoni G. Canine Models of Atopic Dermatitis: A Useful Tool with Untapped Potential. J Invest Dermatol 2009; 129 (10) 2351-2357.
  • 11 Marsella R, Nicklin CF, Saglio S, Lopez J. Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study. Vet Dermatol 2004; 15 (05) 294-303.
  • 12 Mills CM, Marks R. Side effects of topical glucocorticoids. Curr Probl Dermatol 1993; 21: 122-231.
  • 13 Mills PC, Cross SE. Regional differences in the in vitro penetration of hydro-cortisone through equine skin. J Vet Pharmacol Ther 2006; 29 (01) 25-30.
  • 14 Mills PC, Cross SE. Transdermal drug delivery: basic principles for the veterinarian. Vet J 2006; 172 (02) 218-233.
  • 15 Mills PC, Magnusson BM, Cross SE. Effects of vehicle and region of application on absorption of hydrocortisone through canine skin. Am J Vet Res 2005; 66 (01) 43-47.
  • 16 Moriello KA, Verbrugge M. Use of isolated infected spores to determine the sporocidal efficacy of two commercial antifungal rinses against Microsporum canis. Vet Dermatol 2007; 18 (01) 55-58.
  • 17 Mueller RS. Topical dermatological therapy. In Small Animal Clinical Pharmacology. 2nd ed. Maddison JE, Page SW, Church DB. eds Philadelphia: Saunders; 2008
  • 18 Murayama N, Midorikawa K, Nagata M. A case of superficial suppurative necrolytic dermatitis of miniature schnauzers with identification of a causative agent using patch testing. Vet Dermatol 2008; 19 (06) 395-399.
  • 19 Nuttall T, Mueller R, Bensignor E, Verde M, Noli C, Schmidt V, Reme C. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial. Vet Dermatol 2009; 20 (03) 191-198.
  • 20 Olivry T, Marsella R, Hillier A. The ACVD task force on canine atopic dermatitis (XXIII): are essential fatty acids effective?. Vet Immunol Immunopathol 2001; 81 3–4 347-362.
  • 21 Olivry T, Sousa CA. The ACVD task force on canine atopic dermatitis (XX): glucocorticoid pharmacotherapy. Vet Immunol Immunopathol 2001; 81 3–4 317-322.
  • 22 Paterson S. Miconazole/chlorhexidine shampoo as an adjunct to systemic therapy in controlling dermatophytosis in cats. J Small Anim Pract 1999; 40 (04) 163-166.
  • 23 Perrins N, Bond R. Synergistic inhibition of the growth in vitro of Microsporum canis by miconazole and chlorhexidine. Vet Dermatol 2003; 14 (02) 99-102.
  • 24 Piekutowska A, Pin D, Reme CA, Gatto H, Haftek M. Effects of a topically ap-plied preparation of epidermal lipids on the stratum corneum barrier of atopic dogs. J Comp Pathol 2008; 138 (04) 197-203.
  • 25 Reines I, Kietzmann M, Mischke R, Tschernig T, Luth A, Kleuser B, Baumer W. Topical application of sphingosine-1-phosphate and FTY720 attenuate allergic contact dermatitis reaction through inhibition of dendritic cell migration. J Invest Dermatol 2009; 129 (08) 1954-1962.
  • 26 Reiter LV, Torres SM, Wertz PW. Characterization and quantification of ceramides in the nonlesional skin of canine patients with atopic dermatitis compared with controls. Vet Dermatol 2009; 20 (04) 260-266.
  • 27 Reme CA, Mondon A, Calmon JP, Poisson L, Jasmin P, Carlotti DN. Efficacy of combined topical therapy with anti allergic shampoo and lotion for the control of signs associated with atopic dermatitis in dogs. Vet Dermatol 2004; 15 Suppl (Suppl. 01) 33
  • 28 Rosenkrantz W. Practical applications of topical therapy for allergic, infectious, and seborrheic disorders. Clin Tech Small Anim Pract 2006; 21 (03) 106-116.
  • 29 Schmidt V, McEwan N, Nuttall T. Hydrocortisone aceponate. J Small Anim Pract 2009; 50 (06) 317
  • 30 Scott DW, Miller WH, Griffin CE. Muller and Kirk’s Small Animal Dermatology. Philadelphia: Saunders; 2001: 457-476.
  • 31 Shanley KJ. The seborrheic disease complex. An approach to underlying causes and therapies. Vet Clin North Am Small Anim Pract 1990; 20 (06) 1557-1577.
  • 32 Sparkes AH, Robinson A, MacKay AD, Shaw SE. A study of the efficacy of topical and systemic therapy for the treatment of feline Microsporum canis infection. J Feline Med Surg 2000; 2 (03) 135-142.